SELECT B Share Price Performance
SEK 0
0.00 (0.00%)
Price SEK 0
Share Pricen/a
Selectimmune Pharma AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
SELECT B Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Selectimmune Pharma AB (publ) Key Details
About SELECT B
- Founded
- 2017
- Employees
- 2
- CEO
- WebsiteView website
Selectimmune Pharma AB (publ), a pharmaceutical company, develops drugs for the treatment of acute and chronic infections. The company products include IL-1 receptor antagonists, as well as NK1R, RNA Pol II, and IRF7 inhibitors. It has a collaboration agreement with Lonza to develop processes for NlpD, an immunotherapy protein. The company was incorporated in 2017 and is based in Lund, Sweden.
